282 related articles for article (PubMed ID: 31230034)
1. Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study.
Kim SJ; Kwon OD; Cho B; Oh SW; Lee CM; Choi HC
BMJ Open; 2019 Jun; 9(6):e029862. PubMed ID: 31230034
[TBL] [Abstract][Full Text] [Related]
2. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
3. Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs.
Wang TD; Chen YH; Huang CH; Chen WJ; Chen MF
Hypertension; 2014 May; 63(5):958-67. PubMed ID: 24446059
[TBL] [Abstract][Full Text] [Related]
4. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens.
Zeng F; Patel BV; Andrews L; Frech-Tamas F; Rudolph AE
Curr Med Res Opin; 2010 Dec; 26(12):2877-87. PubMed ID: 21067459
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.
Ishida T; Oh A; Hiroi S; Shimasaki Y; Nishigaki N; Tsuchihashi T
Hypertens Res; 2019 Feb; 42(2):249-256. PubMed ID: 30443023
[TBL] [Abstract][Full Text] [Related]
6. Impact of number of medications and age on adherence to antihypertensive medications: A nationwide population-based study.
Kim SJ; Kwon OD; Han EB; Lee CM; Oh SW; Joh HK; Oh B; Kwon H; Cho B; Choi HC
Medicine (Baltimore); 2019 Dec; 98(49):e17825. PubMed ID: 31804305
[TBL] [Abstract][Full Text] [Related]
7. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
[TBL] [Abstract][Full Text] [Related]
8. Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy.
Rea F; Morabito G; Savaré L; Pathak A; Corrao G; Mancia G
J Hypertens; 2023 Sep; 41(9):1466-1473. PubMed ID: 37432906
[TBL] [Abstract][Full Text] [Related]
9. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
Hsiao FC; Tung YC; Chou SH; Wu LS; Lin CP; Wang CL; Lin YS; Chang CJ; Chu PH
Medicine (Baltimore); 2015 Dec; 94(51):e2355. PubMed ID: 26705234
[TBL] [Abstract][Full Text] [Related]
10. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
[TBL] [Abstract][Full Text] [Related]
11. The association of angiotensin receptor blocker-based combination therapy with persistence and adherence in newly treated, uncomplicated hypertensive patients.
Ah YM; Shin J; Lee JY
Patient Prefer Adherence; 2019; 13():241-248. PubMed ID: 30774320
[TBL] [Abstract][Full Text] [Related]
12. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
Sung J; Ahn KT; Cho BR; Lee SY; Kim BJ; Kim DK; Park JI; Lee WS
Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
Lu Y; Van Zandt M; Liu Y; Li J; Wang X; Chen Y; Chen Z; Cho J; Dorajoo SR; Feng M; Hsu MH; Hsu JC; Iqbal U; Jonnagaddala J; Li YC; Liaw ST; Lim HS; Ngiam KY; Nguyen PA; Park RW; Pratt N; Reich C; Rhee SY; Sathappan SMK; Shin SJ; Tan HX; You SC; Zhang X; Krumholz HM; Suchard MA; Xu H
JAMA Netw Open; 2022 Mar; 5(3):e223877. PubMed ID: 35323951
[TBL] [Abstract][Full Text] [Related]
14. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients.
Panjabi S; Lacey M; Bancroft T; Cao F
J Am Soc Hypertens; 2013; 7(1):46-60. PubMed ID: 23321404
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns of antihypertensive fixed-dose combinations according to age and number of agents prescribed: Retrospective analysis using a Japanese claims database.
Ishida T; Oh A; Nishigaki N; Tsuchihashi T
Geriatr Gerontol Int; 2019 Nov; 19(11):1077-1083. PubMed ID: 31436025
[TBL] [Abstract][Full Text] [Related]
16. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.
Verma AA; Khuu W; Tadrous M; Gomes T; Mamdani MM
PLoS Med; 2018 Jun; 15(6):e1002584. PubMed ID: 29889841
[TBL] [Abstract][Full Text] [Related]
17. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
18. Medication compliance and clinical outcomes of fixed-dose combinations vs free combinations of an angiotensin II receptor blocker and a calcium channel blocker in hypertension treatment.
Tung YC; Huang YC; Wu LS; Chang CJ; Chu PH
J Clin Hypertens (Greenwich); 2017 Oct; 19(10):983-989. PubMed ID: 28560786
[TBL] [Abstract][Full Text] [Related]
19. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY
J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055
[TBL] [Abstract][Full Text] [Related]
20. Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
Hiroi S; Shimasaki Y; Kikuchi T; Otsuka Y; Iwasaki K; Ohishi M
Hypertens Res; 2016 Dec; 39(12):907-912. PubMed ID: 27465576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
